Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)

NARecruitingINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
AneurysmAneurysm, Intracranial
Interventions
DEVICE

Surpass Elite with Guardian Flow Diverter System

The Surpass Elite with Guardian Flow Diverter System is indicated for use in the endovascular treatment of adults (age 18 or above) with unruptured wide-neck saccular or fusiform intracranial aneurysms arising from a parent vessel with a diameter ≥ 3.0 millimeter (mm) and ≤ 6.0 mm and located on the Internal Carotid Artery (ICA) or its branches.

Trial Locations (2)

85711

RECRUITING

Carondelet St. Joseph's Hospital, Tucson

01803

RECRUITING

Lahey Hospital and Medical Center, Burlington

All Listed Sponsors
lead

Stryker Neurovascular

INDUSTRY

NCT06872684 - Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD) | Biotech Hunter | Biotech Hunter